 INDIANAPOLIS, May 19, 2022 GLOBE NEWSWIRE -- POINT Biopharma Global Inc. NASDAQ: PNT the Company or POINT, a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, today announced that the Companys Chief Executive Officer, Dr. Joe McCann, will participate in the following upcoming investor conferences. 